Etoperidone

This classification denotes an antiemetic agent with the molecular formula C19H28ClN5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KAI6MVO39Z, chemically known as 1,2,4-triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-4,5-diethyl-2,4-dihydro- but generally known as etoperidone, which bears US NIH Compound Identifier 40589. European Medicines Agency schedules Etoperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07336MIG. The term ETOPERIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules etoperidone in its Anatomical Therapeutic Chemical (ATC) Classification. ETOPERIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etoperidone under HS 29335995 and SITC 51576. As of Q4 2014, ETOPERIDONE remains the US FDA Preferred Term for this commodity. Etoperidone bears US NLM identifiers UMLS ID C0059873 and NCI Concept Code C65597. SMILES: Clc1cc(N2CCN(CC2)CCCn2nc(n(c2=O)CC)CC)ccc1.